Brief: Aviva Investors FIO, Aviva Investors Specjalistyczny FIO, Aviva Specjalistyczny FIO PPK Up Their Stake In Pure Biologics To 7.56%
Dec 10 (Reuters) - Pure Biologics SA PUR1.WA :
* SAYS AFTER INCREASING SHARE CAPITAL, AVIVA INVESTORS FIO,
AVIVA
INVESTORS SPECJALISTYCZNY FIO AND AVIVA SPECJALISTYCZNY FIO PPK
TOGETHER UP THEIR STAKE IN COMPANY TO 7.56% FROM 0.45%
Source text for Eikon: ID:nEM1bB3ga
Further company coverage: PUR1.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Multiqure SA
See all newsBrief: Selvita To Expand Its Operations Through New Biological Drug Business
Brief: Pure Biologics FY Net Loss Widens To 25.6 Mln Zlotys
Brief: Pure Biologics Signs Term Sheet With ACRX Investments On Potential Financing
Brief: Pure Biologics Signs Deal For Subsidy With Poland's Medical Research Agency
Brief: Pure Biologics To Seek Extra Financing For PB003 And PB004 Projects